Ferngrove Pharmaceuticals Pty Ltd v Betterway Health Care International Group Pty Ltd

Ferngrove Pharmaceuticals Pty Ltd
v
Betterway Health Care International Group Pty Ltd
[2022] HCASL 156
A13/2022

The applicant seeks special leave to appeal from a unanimous decision of the Court of Appeal of the Supreme Court of South Australia (Kourakis CJ, Doyle and Bleby JJA) to dismiss the applicant's appeal from a decision of the District Court of South Australia (Judge Durrant).
There is no reason to doubt the correctness of the decision of the Court of Appeal. Accordingly, special leave should be refused.
Pursuant to r 41.08.1 of the High Court Rules 2004 (Cth), we direct the Registrar to draw up, sign and seal an order dismissing the application with costs.

S.J. Gageler S.H.P. Steward

19 September 2022

CaseChat Overview and Summary

Ferngrove Pharmaceuticals Pty Ltd filed an application for special leave to appeal against a decision made by the Court of Appeal of the Supreme Court of South Australia, which dismissed their appeal from a ruling by the District Court of South Australia. The original dispute involved Ferngrove Pharmaceuticals, who sought damages for breach of contract and misleading or deceptive conduct against Betterway Health Care International Group. The lower court ruled in favour of Betterway Health Care, and the appeal was subsequently dismissed by the Court of Appeal.

The primary legal issues before the Court of Appeal were whether there was a breach of contract and whether the conduct of Betterway Health Care amounted to misleading or deceptive conduct. The Court of Appeal found that there was no breach of contract and that Betterway Health Care's conduct did not meet the criteria for misleading or deceptive conduct. The applicant, Ferngrove Pharmaceuticals, sought special leave to appeal this decision to the High Court, arguing that the Court of Appeal erred in its interpretation of the law and the facts of the case.

The High Court considered the arguments presented by Ferngrove Pharmaceuticals and found that there were no grounds to doubt the correctness of the Court of Appeal's decision. The Court concluded that the appeal should be dismissed, and no special leave to appeal should be granted. The Court further directed the Registrar to prepare an order dismissing the application with costs.

The final orders of the High Court dismissed the application for special leave to appeal and ordered Ferngrove Pharmaceuticals to pay the costs of the appeal. The decision of the Court of Appeal stands, and the lower court's ruling in favour of Betterway Health Care remains intact.

CaseChat Overview and Summary

Orders of the court

Background to the litigation

Evidence Before The Court

Reasons for decision

Legal Principle Established